Cervical cancer is a common gynecological malignancy in women. The specific survival time of patients depends on the malignancy degree of the lesion and the patient’s own condition, and cannot be generalized. Cervical cancer is divided into early, middle and late stages, and the treatment methods vary according to the stages, and the prognosis is also different. If cervical cancer can be detected at an early stage, it is usually treated by surgical excision. If the patient is in good health and there is no metastasis, the 5-year survival rate can reach over 90%, which means there is a possibility of long-term survival. However, for patients with middle and late stage cervical cancer or those with distant organ metastasis, surgery is usually not possible and radiotherapy can only be used to slow down the disease, and the survival period of patients will be significantly affected, usually around 3-5 years, or even shorter in severe cases. Therefore, if patients have cervical inflammation, they should go for cervical cancer screening regularly every year to achieve early prevention, early detection and early treatment.